Benzinga | Nov 2, 2021 04:20PM EDT

Deciphera Pharmaceuticals Q3 EPS $(1.37) Misses $(1.28) Estimate, Sales $23.20M Miss $23.36M Estimate

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(1.28) by 7.03 percent. This is a 21.24 percent decrease over losses of $(1.13) per share from the same period last year. The company reported quarterly sales of $23.20 million which missed the analyst consensus estimate of $23.36 million by 0.68 percent. This is a 50.17 percent increase over sales of $15.45 million the same period last year.